Article

Exploring the Potential of Radiomics Features of the Hippocampus in Alzheimer’s Disease Considering Standard versus Parallel Imaging

Wiley
Alzheimer's & Dementia
Authors:
To read the full-text of this research, you can request a copy directly from the authors.

Abstract

Background Radiomics features obtained from anatomical magnetic resonance imaging (MRI) have been showing potential as biomarkers for the diagnosis of Alzheimer’s disease (AD). Nevertheless, little is known about how accelerated parallel MRI acquisitions impact such features and their potential in diagnosing AD. Therefore, this study aimed to compare the radiomics features extracted from the hippocampus considering standard and parallel imaging. Method A total of 235 age and gender‐matched subjects (128 cognitively normal (CN) and 107 AD) with both T1‐weighted MPRAGE (standard) and accelerated MPRAGE GRAPPA or SENSE images were selected from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Freesurfer was used to process the images and to obtain the volumes of these regions: hippocampus, entorhinal cortex, amygdala, and inferior lateral ventricle (summed bilaterally); and caudal and rostral midfrontal, pars opercularis, pars triangularis, inferior parietal, superior parietal, supramarginal, and superior temporal gyri (all summed into one feature). Using Pyradiomics, the following radiomics features from the bilateral hippocampus were extracted: kurtosis, mean, range, contrast, elongation, flatness, and maximum 3D diameter. To compare the two acquisitions (standard vs parallel), support vector machine models were created to classify AD vs CN. To mitigate AD heterogeneity in ADNI, 5‐fold cross‐validation was used to create 5 train and test sets based on the hippocampus volumes: (each train fold has 80% of 1 st quartile AD and 80% 1 st quartile CN, and the test fold has 20% of 1 st quartile AD and 20% 1 st quartile CN volumes, and so on – randomly selected). Result Adding radiomics features improved the classification of AD vs CN in both acquisitions (Table 1): the positive predictive value increased from 77.2% to 90.3% in the standard, while the negative predictive value increased to 84.7% to 91.6% in the parallel acquisition. In both cases, models using all volumes surpassed those using only the hippocampus volume by 7.4% (86.0% balanced accuracy, standard) and 4.2% (85.5%, balanced accuracy, parallel) (Table 1). Conclusion Radiomics features of the hippocampus improve the performance of the models in both acquisitions, but with different predictive values, confirming their potential. Also, the relevance of other brain regions in AD besides the hippocampus was observed.

No full-text available

Request Full-text Paper PDF

To read the full-text of this research,
you can request a copy directly from the authors.

... Radiomics allows us to obtain imaging features that the naked eye cannot detect. Therefore, by analyzing these features (imaging biomarkers) it is possible to gain a deeper insight into the disease [7]. By prioritizing explainability and transparency, radiomics helps to build trust in AI-driven decision-making, ultimately leading to better patient outcomes [8,9]. ...
... Additionally, the model achieved an average accuracy of 0.875, signifying a high proportion of patients were correctly classified. Furthermore, the model demonstrated exceptional sensitivity (0.914) for detecting individuals with homozygous ApoE4, highlighting its effectiveness in 7 identifying this specific patient group. The model also maintained good specificity (0.838) in correctly identifying MCI patents without the ApoE4 genotype. ...
Preprint
Full-text available
Objective: Fludeoxyglucose F18 positron emission tomography (FDG PET) can give early clues for diagnosing Alzheimer’s disease (AD). Our objective was to use the same scan to predict Apolipoprotein E4 (ApoE4), known to be a risk factor. A second objective was to determine the brain regions and imaging features associated with this gene allele that can potentially help elucidate the mechanisms of the disease and better comprehend the images. Method: We employed data from 112 participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). PET and structural MRI data were co-registered with ANTx, and the Freesurfer tool delineated 95 whole brain, 19 hippocampal, and 9 amygdala regions. Using PyRadiomics we extracted 120 radiomic features from these segments. We employed a hybrid feature selection strategy. The HistGradientBoosting (HGB) classifier was evaluated using stratified five-fold cross-validation. Results: The proposed radiomics model predicted the homozygous ApoE4 genotype, with an AUC of 0.945 an accuracy of 0.875, a sensitivity of 0.914, and a specificity of 0.838. Reducing the feature set to seven key features resulted in a slightly decreased performance (AUC: 0.889). The mean values of the features showed statistically significant (p<0.05) incremental deterioration between different groups of homozygous ApoE4 carriers. Conclusion: Our findings underscore the critical role of specific brain regions and associated features in differentiating ApoE4 carriers. The hippocampus, entorhinal cortex, amygdala, thalamus, and pars orbitalis exhibited significant associations with the ApoE4 genotype. By employing SHAP analysis, we identified key features driving model predictions, enhancing interpretability, and providing insights into the underlying pathophysiology.
ResearchGate has not been able to resolve any references for this publication.